References
- Buchanan G R. The non treatment of childhood idiopathic thrombocytopenic purpura. Eur J Pediatr 1987; 146: 106–112
- Cohn J. Thrombocytopenia in childhood: an evaluation of 433 patients. Scand J Haematol 1976; 16: 226–240
- Buchanan G R, Holrkamp C A. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial. Am J Pediatr Hematol Oncol 1984; 6: 355–361
- Imbach P, D'Apuzzo V, Hirt A. High dose intravenous gammaglobulin for idiopathic purpura in childhood. Lancet 1981; 2: 1228–1231
- Imbach P. Intravenous immunoglobulin therapy for idiopathic thrombocytopenic purpura and other immune-related disorders: review and update of our experiences. Pediatr Infect Dis J 1988; 7: 120–125
- Bussel J B, Schulman I, Hilgartner M W, Barandum S. Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy. J. Pediatr 1983; 103: 651–654
- Imholz B, Imbach P, Baumgartner C. Intravenous immunoglobulin (IV IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: a prospective multicenter study. Blood 1988; 56: 63–68
- Vermylen C, Bugnon F, Niname J, Cornu G. Treatment of immune thrombocytopenic purpura in childhood. Acta Clin Belg 1990; 45: 120–125
- Ozsoylu S. High-dose intravenous methyl-prednisolone for the treatment of childhood chronic idiopathic thrombocytopenic purpura. Pediatr Rev Commun 1987; 229–240
- Schreiber A D, Chien P, Tomaski A. Effect of danazol in immune thrombocytopenic purpura. N Engl J Med 1987; 316: 503–508
- Bussel J B, Graziano Z N, Kimberly R P. Intravenous anti-DNA treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity and mechanism of effect. Blood 1991; 77: 1884–1893
- Russell E C. Alternatives to splenectomy in the management of chronic idiopathic thrombocytopenic purpura in childhood. Am J Pediatr Hematol Oncol 1984; 6: 175–179
- Lilleyman J S. Chronic idiopathic thrombocytopenic purpura: the pediatrician's dilemma. Pediatr HematoE Oncol 1990; 7: 115–118
- Cramer P, Kasse M C, Aujard Y. Cerebromeningeal hemorrhage in the initial stage of idiopathic thrombocytopenic purpura. Arch Pediatr 1983; 40: 105–107
- Brenner B, Guilburd J N, Tatarsky I. Spontaneous intracranial hemorrhage in immune thrombocytopenic purpura. Neurosurgmy 1988; 22: 761–764
- Lammi A T, Lovric V A. Idiopathic thrombocytopenic purpura: an epidemiologic study. J Pediatr 1973; 83: 31–36
- Imbach P, Barandun S, Cottier H. Immunomodulation by intravenous immunoglobulin. Am J Pediatr Hematol Oncol 1990; 12: 134–140
- Hollenberg J P, Subak L L, Ferry J J. Cost-effectiveness of splenectomy versus intravenous gamma globulin in treatment of chronic immune thrombocytopenic purpura in childhood. J Pediatr 1988; 112: 530–539
- Imbach P, Perret B A, Babington R. Safety of intravenous immunoglobulin preparations. A prospective multicenter study to exclude the risk of non-A, non-B hepatitis. Vox Sang 1991; 61: 1–4
- Wanachiwanawin W, Visudhiphan S, Piankijagum A, Vatanavicharn S. Serious complications following treatment of chronic idiopathic thrombocytopenic purpura. Postgrad Med J 1988; 64: 426–430